Recommended Pages at skinandaging.com
Advances in Diagnosing Non-melanoma Skin Cancers | Skin & Aging
skinandaging.com — “Advances in Diagnosing Non-melanoma Skin Cancers | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on February 24, 2012 at 4:15 pm By:
Skin & Aging Dermatology and Medical Journal
Did you read the February feature on advances in diagnosing non-melanoma skin cancers? Access it online. http://t.co/GNj465OF
Listen to Your Skin Campaign Will Raise Awareness about Sun Damage | Skin & Aging
skinandaging.com — “Listen to Your Skin Campaign Will Raise Awareness about Sun Damage | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on February 23, 2012 at 5:13 pm By:
Skin & Aging Dermatology and Medical Journal
The American Academy of Dermatology and Leo Pharmaceuticals have rolled out a joint initiative to increase... http://t.co/MxMLHZNZ
Syneron Medical Announces Energy-based Dermal Remodeling Procedure | Skin & Aging
skinandaging.com — “Syneron Medical Announces Energy-based Dermal Remodeling Procedure | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on February 8, 2012 at 4:11 pm By:
Skin & Aging Dermatology and Medical Journal
The latest device from Syneron delivers controlled radiofrequency energy directly into the deep dermis,... http://t.co/k6rpDRUq
California Settlement Requires Brazilian Blowout Manufacturers to Change Advertising and Labeling Practices | Skin & Aging
skinandaging.com — “California Settlement Requires Brazilian Blowout Manufacturers to Change Advertising and Labeling Practices | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on January 31, 2012 at 6:47 pm By:
Skin & Aging Dermatology and Medical Journal
A new settlement in California is the first to address the formaldehyde exposures that occur with the Brazilian... http://t.co/antVMAxL
FDA Approves New Topical Treatment for Actinic Keratosis | Skin & Aging
skinandaging.com — “FDA Approves New Topical Treatment for Actinic Keratosis | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on January 25, 2012 at 4:42 pm By:
Skin & Aging Dermatology and Medical Journal
Ingenol mebutate (Picato) gel (0.015%, 0.05%) is the first and only topical AK therapy that can be used for as... http://t.co/vs1JtWNn
FDA Grants Approval to Move Forward with Phase III Trial of Metastatic Melanoma Drug PV-10 | Skin & Aging
skinandaging.com — “FDA Grants Approval to Move Forward with Phase III Trial of Metastatic Melanoma Drug PV-10 | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on January 19, 2012 at 6:56 pm By:
Skin & Aging Dermatology and Medical Journal
The Phase III review will be conducted through either standard review or with a request for a Special Protocol... http://t.co/phmdG7L1
News and Trends | Skin & Aging
skinandaging.com — “News and Trends | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on January 17, 2012 at 3:40 pm By:
Skin & Aging Dermatology and Medical Journal
Check out the January News and Trends for online-only content. http://t.co/WgX3GVUf
Novel Understanding of Psoriasin Protein May Lead to New Treatments for Psoriasis | Skin & Aging
skinandaging.com — “Novel Understanding of Psoriasin Protein May Lead to New Treatments for Psoriasis | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on January 11, 2012 at 3:46 pm By:
Skin & Aging Dermatology and Medical Journal
Inhibition of the psoriasin protein may be a novel treatment method for psoriasis, new research reveals. http://t.co/sAwb0DiC
Astellas Pharma US Announces Discontinuation of Manufacturing for Amevive | Skin & Aging
skinandaging.com — “Astellas Pharma US Announces Discontinuation of Manufacturing for Amevive | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on January 6, 2012 at 2:10 pm By:
Skin & Aging Dermatology and Medical Journal
Astellas Pharma US, manufacturer of alefacept (Amevive), has announced its decision to cease sales of Amevive,... http://t.co/2obf8lep
Hydrogel Results in Scar-free, Healthy Skin after Third Degree Burn Injury | Skin & Aging
skinandaging.com — “Hydrogel Results in Scar-free, Healthy Skin after Third Degree Burn Injury | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on December 22, 2011 at 6:32 pm By:
Skin & Aging Dermatology and Medical Journal
A hydrogel-infused wound dressing developed by researchers at Johns Hopkins has demonstrated the ability to... http://t.co/pWWdymjB
Year in Review 2011 | Skin & Aging
skinandaging.com — “Year in Review 2011 | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on December 19, 2011 at 12:21 pm By:
Skin & Aging Dermatology and Medical Journal
A review of clinically relevant discoveries and techniques in dermatology during 2011. http://t.co/ghHr26QB
Research with Roundworm Provides New Insight into Wound Repair Process | Skin & Aging
skinandaging.com — “Research with Roundworm Provides New Insight into Wound Repair Process | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on November 22, 2011 at 8:16 pm By:
Skin & Aging Dermatology and Medical Journal
Researchers at the University of California San Diego working with the laboratory roundworm C. elegans have... http://t.co/QtmifnIN
Allergic Contact Dermatitis: Hand Dermatitis | Skin & Aging
skinandaging.com — “Allergic Contact Dermatitis: Hand Dermatitis | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on November 16, 2011 at 8:49 pm By:
Skin & Aging Dermatology and Medical Journal
Don't miss this month's Allergen Focus on hand dermatitis. http://t.co/V3hyHN28
Recent Research from the Journal of the American Academy of Dermatology | Skin & Aging
skinandaging.com — “Recent Research from the Journal of the American Academy of Dermatology | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on November 16, 2011 at 8:12 pm By:
Skin & Aging Dermatology and Medical Journal
The December issue of the American Academy of Dermatology is now online. Click on the link below to preview some... http://t.co/Xsg6Riqk
Vismodegib, Investigational Drug for Basal Cell Carcinoma, Receives Priority Review Status from the FDA | Skin & Aging
skinandaging.com — “Vismodegib, Investigational Drug for Basal Cell Carcinoma, Receives Priority Review Status from the FDA | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on November 11, 2011 at 6:52 pm By:
Skin & Aging Dermatology and Medical Journal
Vismodegib, an investigational drug for the treatment of advanced basal cell carcinoma, has been granted Priority... http://t.co/seXufeuH
